Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study
Guillermo Bosch, View ORCID ProfileMargarita Posso, Javier Louro, Marta Roman, Miquel Porta, Xavier Castells, Francesc Macià
doi: https://doi.org/10.1101/2022.03.04.22271911
Guillermo Bosch
1Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
2Preventive Medicine and Public Health Training Unit PSMar-ASPB-UPF, Barcelona, Spain
MDMargarita Posso
1Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
3Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Barcelona, Spain
MD, PhDJavier Louro
1Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
3Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Barcelona, Spain
PhDMarta Roman
1Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
3Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Barcelona, Spain
PhDMiquel Porta
4Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
5Hospital del Mar Institute of Medical Research (IMIM PSMar), Barcelona, Catalonia, Spain
6Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain
MD, PhDXavier Castells
1Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
3Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Barcelona, Spain
4Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
MD, PhDFrancesc Macià
1Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
3Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), Barcelona, Spain
MD
Data Availability
Source data form all tables and figures can be found in the following Dataset: BOSCH, GUILLERMO, 2022, "Breast cancer screening program invitations (2012-2021)", https://doi.org/10.7910/DVN/VVQNWM, Harvard Dataverse, V1, UNF:6:CaW3sEp4tMsg13z2I1eZbQ== [fileUNF] Data from "Impact on covid19 dataset invited women.sav" was used in tables 1 and 2 and figures 1,2 and 3. Data from "cancer characteristics database.tab" was used in table 3.
Posted March 07, 2022.
Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study
Guillermo Bosch, Margarita Posso, Javier Louro, Marta Roman, Miquel Porta, Xavier Castells, Francesc Macià
medRxiv 2022.03.04.22271911; doi: https://doi.org/10.1101/2022.03.04.22271911
Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study
Guillermo Bosch, Margarita Posso, Javier Louro, Marta Roman, Miquel Porta, Xavier Castells, Francesc Macià
medRxiv 2022.03.04.22271911; doi: https://doi.org/10.1101/2022.03.04.22271911
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (728)
- Anesthesia (215)
- Cardiovascular Medicine (3126)
- Dermatology (265)
- Emergency Medicine (464)
- Epidemiology (13076)
- Forensic Medicine (14)
- Gastroenterology (868)
- Genetic and Genomic Medicine (4895)
- Geriatric Medicine (451)
- Health Economics (755)
- Health Informatics (3089)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (973)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4664)
- Nursing (248)
- Nutrition (691)
- Oncology (2405)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (519)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7231)
- Radiology and Imaging (1613)
- Respiratory Medicine (945)
- Rheumatology (462)
- Sports Medicine (403)
- Surgery (518)
- Toxicology (65)
- Transplantation (222)
- Urology (193)